By Adenike Lawal
Human papillomavirus (HPV) encompasses a group of over 200 related viruses, some of which can lead to warts in various areas of the body. Among these, around 40 types are known to be transmitted through direct sexual contact, with the potential for spread through intimate skin-to-skin interactions. Notably, certain high-risk strains of HPV are associated with several forms of cancer, making awareness and prevention crucial.
HPV can be classified into two categories based on their risk levels concerning sexual transmission: low-risk and high-risk. Low-risk HPV strains may lead to the development of warts around the genitals, anus, mouth, or throat. In contrast, high-risk HPV types are linked to several cancers, including:
Cervical cancer
Anal cancer
Vulvar cancer
Vaginal cancer
Penile cancer
Some oral and throat cancers
While the majority of HPV infections resolve spontaneously without resulting in cancer, some infections can persist for years and lead to cellular changes. If these changes go unaddressed, they may progress into cancer, emphasizing the need for regular medical check-ups and screenings.
HPV infections are highly prevalent, with nearly all sexually active individuals contracting the virus shortly after they begin sexual activity. The widespread nature of HPV highlights the importance of education and awareness surrounding the virus.
While certain low-risk HPV strains can cause visible warts, most high-risk types often do not present any noticeable symptoms. If a high-risk HPV infection persists for several years and results in cellular changes, symptoms may emerge, particularly if those changes advance to cancer. The symptoms experienced will vary based on the area of the body affected.
Healthcare providers typically diagnose warts through visual examinations. For women, cervical cancer screening tests, including Pap tests and HPV tests, can detect precancerous changes in the cervix. These screenings are essential for early detection and intervention, particularly in populations at higher risk.
Currently, there is no definitive treatment to eliminate HPV infections themselves; however, various treatments are available for the conditions it causes. Topical medications can address warts, and if these are ineffective, healthcare providers may resort to freezing, burning, or surgically removing the warts. Treatments are also available for cellular changes induced by high-risk HPV, including both topical therapies and surgical interventions.
Individuals diagnosed with HPV-related cancers typically receive treatments comparable to those for cancers not linked to HPV, although some oral and throat cancers may have unique treatment protocols.
Consistent and correct use of latex condoms can significantly reduce, though not entirely eliminate, the risk of HPV transmission. For those allergic to latex, polyurethane condoms serve as a suitable alternative. The most effective way to avoid HPV infection is through complete abstinence from anal, vaginal, or oral sex.
Vaccination offers a proactive approach to preventing HPV infections, particularly against strains that can lead to cancer. These vaccines are most effective when administered before individuals become sexually active, underscoring the importance of early education and vaccination efforts.
In Nigeria, an estimated 60.9 million women aged 15 years and older are at risk of developing cervical cancer. Current statistics reveal that approximately 12,075 women are diagnosed with cervical cancer each year, making it the second most prevalent cancer among women in the country, especially affecting those between the ages of 15 and 44. Alarmingly, around 30% of women in the general population are estimated to harbor cervical HPV-16/18 infections at any given time, with 66.9% of invasive cervical cancers attributable to these high-risk HPV types.
The prevalence of HPV and its associated risks, particularly in the context of cervical cancer in Nigeria, highlights an urgent need for increased awareness, preventive measures, and accessible healthcare resources. Community education on HPV transmission, regular screenings, and vaccination campaigns are critical in combating the impact of HPV and safeguarding women’s health across the nation. By prioritizing these initiatives, Nigeria can take significant strides towards reducing the burden of cervical cancer and enhancing overall public health.
